Author:
Zamanian Mohammad Yasin,Nazifi Mozhgan,Khachatryan Lusine G.,Taheri Niloofar,Ivraghi Mehraveh Sadeghi,Menon Soumya V.,Husseen Beneen,Prasad K. D. V.,Petkov Iliya,Nikbakht Nikta
Publisher
Springer Science and Business Media LLC
Reference102 articles.
1. Kumar, S., L. Goyal, and S. Singh. 2022. Tremor and rigidity in patients with Parkinson’s disease: Emphasis on epidemiology, pathophysiology and contributing factors. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders) 21 (7): 596–609.
2. Huang, M., et al. 2022. Impact of environmental risk factors on mitochondrial dysfunction, neuroinflammation, protein misfolding, and oxidative stress in the etiopathogenesis of parkinson’s disease. International journal of molecular sciences 23 (18): 10808.
3. Mani, S., et al. 2021. A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson’s disease. Neurological Sciences 42 (11): 4459–4469.
4. Johnson, M.E., et al. 2019. Triggers, facilitators, and aggravators: Redefining Parkinson’s disease pathogenesis. Trends in Neurosciences 42 (1): 4–13.
5. Wang, T., et al. 2022. Neuroinflammation in Parkinson’s disease: Triggers, mechanisms, and immunotherapies. The Neuroscientist 28 (4): 364–381.